USPTO serial 79359491
Reviewed by CopyMark Law Group
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Enzymes derived from biotechnological processes for use in industry; enzymes, other than for medical use, for use in the continuous homogenous isothermal amplifications of specific DNA templates for scientific and research purposes; industrial chemicals; chemicals e.g. reagents, materials, manufacturing process components for use in separation other than medical or veterinary purposes including biotechnological, biochemical, chemical and pharmaceutical catalysts; catalysts for chemical and biochemical processes; enzymes for use as biochemical catalysts for industrial purposes; chemicals used in industry, science and photography, agriculture, horticulture and forestry, namely, chemicals, e.g. reagents, materials, manufacturing process components for the separation and purification of mixtures, and for the isolation of substances; chemical products, namely proteins for use in chromatographic processes, other than for medical purposes; chromatographic chemical materials, namely proteins for the treatment of biopolymers, not for medical treatment; artificial porous unprocessed resins for chromatographic purposes; all the aforesaid goods also provided as part of kits. | ACTIVE | — |
| 005 | Ferments for pharmaceutical purposes; enzymes for medical purposes | ACTIVE | — |
| 042 | Chemical research; chemical analytical examinations, namely executing of chemical analysis, quality control, composition control; chemical analysis; biochemical analysis; laboratory analysis in the field of chemistry; analysis of product development, namely product development consultation, composition confirmations, nucleic acid purification efficacy monitoring, chemical, biotechnological, pharmaceutical manufacturing feasibility testing; biotechnological scientific research relating to enzymatic synthesis; scientific research relating to biotechnology; chemical research; chemical technological research; research and development of biotechnology in the field of chemistry, synthetic biology, biotechnology, pharmacy, diagnostics, food processing; chemical analysis services for use in design; chemical analysis services for use in the testing of material. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 7, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 16, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 28, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 28, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 28, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 18, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 31, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 31, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 11, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 10, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 9, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 10, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 6, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 5, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |